Gary Calandra

8.4k citations
104 papers · 6.2k · 3 hit papers · h-index 39

Impact in

  • Hematology top 0.2%
    • Hematopoietic Stem Cell Transplantation
    • Multiple Myeloma Research and Treatments
    • Acute Myeloid Leukemia Research
  • Immunology top 1%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

Gary Calandra

103 papers receiving 5.9k citations

Gary Calandra's Hit Papers

Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma 2009 · 512 citations
5120+7+15Years since publication250500750

Peers

Gary Calandra
Comparison fields: 5 of 119
  • Hematology 2.4k
  • Immunology 1.8k
  • Hepatology 630
  • Oncology 1.8k
  • Genetics 552
Replace Steven H. Sacks with:
Steven H. Sacks United Kingdom
Carlos V. Payá United States
Soohyun Kim South Korea
Ineke J. M. ten Berge Netherlands
Richard P. MacDermott United States
Carolyn Mold United States
Stephan Ehl Germany
José L. Cohen France
Craig A. Mullen United States
Insoo Kang United States
Gary Calandra relative to Steven H. Sacks United Kingdom Steven H. Sacks's profile →
Citations per field
00.5×4.8×
Steven H. Sacks · 1×
Citations per year

Countries citing papers authored by Gary Calandra

Since Specialization
Citations

This map shows the geographic impact of Gary Calandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Calandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Calandra more than expected).

Fields of papers citing papers by Gary Calandra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Calandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Calandra. The network helps show where Gary Calandra may publish in the future.

Co-authors

The 25 scholars most cited alongside Gary Calandra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary Calandra Line = papers co-authored together Gary Calandra links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
Hit paper breakdown →
2005848
2
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
Hit paper breakdown →
2003561
3
Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma
Hit paper breakdown →
2009512
4 1992389
5 2004327
6 2008234
7 2005177
8 1988169
9 1992157
10 1982141
11 1985112
12 2008107
13 1988106
14 2009103
15 2007103
16 200999
17 200986
18 198579
19 200477
20 197670

About Gary Calandra

Gary Calandra is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Immunology, Epidemiology and Oncology, having authored 104 papers that have together received 6.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (32 papers), Streptococcal Infections and Treatments (20 papers), Acute Myeloid Leukemia Research (14 papers), Immunotherapy and Immune Responses (12 papers), Multiple Myeloma Research and Treatments (12 papers), Chemokine receptors and signaling (11 papers), Neonatal and Maternal Infections (10 papers) and Hepatitis B Virus Studies (9 papers). The work is most often cited by research in Hematology (2.4k citations), Immunology (1.8k citations), Hepatology (630 citations), Oncology (1.8k citations) and Genetics (552 citations). Gary Calandra has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Gary Bridger, John F. DiPersio, David C. Dale, Hal E. Broxmeyer, W. Conrad Liles, Giao Hangoc, Karin Badel, Richard T. Maziarz, Patrick J. Stiff and Ivana N. Micallef. Their work appears in journals such as Biology of Blood and Marrow Transplantation, Clinical Infectious Diseases, Blood, Infection and Immunity and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact